Descovy 200mg/10mg – 200mg/25mg FC tablet
PDF Leaflet Revision Date: 3 November 2020
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of HIV-1 in adults and adolescents (u226512 years, u226535 kg).
Dosage (summary)
200/10 mg or 200/25 mg once daily, depending on the third agent.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy unless no alternatives; avoid breastfeeding.
Key Drug Interactions
- Anticonvulsants
- Rifampicin
- St. John's wort
Contraindications
- Hypersensitivity to active substances
Common side effects
- Nausea
- Diarrhoea
- Headache
- Fatigue
Counselling Points
- Take once daily with or without food
- Monitor for liver function
- Use effective contraception
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Immune reactivation syndrome
Important Disclaimer
The Descovy 200mg/10mg – 200mg/25mg FC tablet professional information leaflet below is the property of Gilead Sciences South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
